You are here

COVID-19 Immunological Investigation: Quality, quantity and kinetics of antibody and cell-mediated responses

COVID-19 Research Area(s): Epidemiology & Public Health, Vaccines & Treatments

To validate SARS-CoV-2 antibody assays in development and to evaluate the type, quantity, quality and kinetics of the immune response. To collect blood from confirmed COVID-19 cases to enable validation of antibody assays, guide timing of specimen collection for serological diagnosis and to support future investigation and fuller understanding of the immune response more generally to COVID-19, other coronaviruses and emerging or re-emerging respiratory pathogens.

Post date: 
Apr 21, 2020